{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:12:13Z","timestamp":1787242333563,"version":"build-2736575974"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T00:00:00Z","timestamp":1643760000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lasers Med Sci"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1007\/s10103-022-03515-1","type":"journal-article","created":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T20:02:29Z","timestamp":1643745749000},"page":"2501-2508","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Morphological outcome and indication for laser following intravitreal bevacizumab monotherapy for posterior retinopathy of prematurity"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3798-6697","authenticated-orcid":false,"given":"Manavi D.","family":"Sindal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6493-5698","authenticated-orcid":false,"given":"C. K.","family":"Nagesha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0692-8729","authenticated-orcid":false,"given":"Divya","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romana","family":"Fazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,2]]},"reference":[{"issue":"S1","key":"3515_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/pr.2013.205","volume":"74","author":"H Blencowe","year":"2013","unstructured":"Blencowe H, Lawn JE, Vazquez T et al (2013) Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatr Res 74(S1):35\u201349","journal-title":"Pediatr Res"},{"key":"3515_CR2","unstructured":"Low birthweight - UNICEF DATA [Internet]. [cited 2021 Jan 1]. Available from: https:\/\/data.unicef.org\/topic\/nutrition\/low-birthweight\/"},{"issue":"6","key":"3515_CR3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.4103\/ijo.IJO_709_18","volume":"67","author":"K Agarwal","year":"2019","unstructured":"Agarwal K, Balakrishnan D, Rani P, Jalali S (2019) Changing patterns of early childhood blinding conditions presenting to a tertiary eye center: The epidemic of retinopathy of prematurity in India. Indian J Ophthalmol 67(6):816","journal-title":"Indian J Ophthalmol"},{"key":"3515_CR4","doi-asserted-by":"crossref","unstructured":"Mintz-Hittner HA, Kennedy KA, Chuang AZ; BEAT-ROP Cooperative Group. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603\u201315.","DOI":"10.1056\/NEJMoa1007374"},{"issue":"10208","key":"3515_CR5","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1016\/S0140-6736(19)31344-3","volume":"394","author":"A Stahl","year":"2019","unstructured":"Stahl A, Lepore D, Fielder A et al (2019) Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial. Lancet 394(10208):1551\u20131559","journal-title":"Lancet"},{"issue":"11","key":"3515_CR6","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1001\/jamaophthalmol.2014.2772","volume":"132","author":"MM Geloneck","year":"2014","unstructured":"Geloneck MM, Chuang AZ, Clark WL et al (2014) Refractive Outcomes Following Bevacizumab Monotherapy Compared With Conventional Laser Treatment: A Randomized Clinical Trial. JAMA Ophthalmol 132(11):1327","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"3515_CR7","first-page":"10","volume":"51","author":"S Jalali","year":"2003","unstructured":"Jalali S, Anand R, Kumar H et al (2003) Programme Planning and Screening Strategy in Retinopathy of Prematurity. Indian J Ophthalmol 51(1):10","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"3515_CR8","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1016\/j.ajo.2005.12.016","volume":"141","author":"S Jalali","year":"2006","unstructured":"Jalali S, Matalia J, Hussain A, Anand R (2006) Modification of Screening Criteria for Retinopathy of Prematurity in India and Other Middle-Income Countries. Am J Ophthalmol 141(5):966\u2013968","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"3515_CR9","doi-asserted-by":"publisher","first-page":"331","DOI":"10.4103\/0301-4738.33817","volume":"55","author":"M Dogra","year":"2007","unstructured":"Dogra M, Sangtam T, Narang A et al (2007) Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: Ten year data from a tertiary care center in a developing country. Indian J Ophthalmol 55(5):331","journal-title":"Indian J Ophthalmol"},{"issue":"5","key":"3515_CR10","doi-asserted-by":"publisher","first-page":"F371","DOI":"10.1136\/fetalneonatal-2011-301121","volume":"97","author":"PK Shah","year":"2012","unstructured":"Shah PK, Narendran V, Kalpana N (2012) Aggressive posterior retinopathy of prematurity in large preterm babies in South India. Arch Dis Child - Fetal Neonatal Ed 97(5):F371\u2013F375","journal-title":"Arch Dis Child - Fetal Neonatal Ed"},{"issue":"03","key":"3515_CR11","doi-asserted-by":"publisher","first-page":"241241","DOI":"10.1055\/s-0030-1268239","volume":"28","author":"J Zisk","year":"2011","unstructured":"Zisk J, Genen L, Kirkby S, Webb D, Greenspan J, Dysart K (2011) Do Premature Female Infants Really Do Better Than Their Male Counterparts? Am J Perinatol. 28(03):241241","journal-title":"Am J Perinatol."},{"issue":"1","key":"3515_CR12","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ajo.2012.06.010","volume":"155","author":"W-C Wu","year":"2013","unstructured":"Wu W-C, Kuo H-K, Yeh P-T et al (2013) An Updated Study of the Use of Bevacizumab in the Treatment of Patients with Prethreshold Retinopathy of Prematurity in Taiwan. Am J Ophthalmol 155(1):150-158.e1","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"3515_CR13","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1001\/archophthalmol.2012.592","volume":"130","author":"J Hu","year":"2012","unstructured":"Hu J, Blair MP, Shapiro MJ et al (2012) Reactivation of Retinopathy of Prematurity After Bevacizumab Injection. Arch Ophthalmol 130(8):1000","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"3515_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.oret.2017.09.021","volume":"2","author":"M Tandon","year":"2018","unstructured":"Tandon M, Vishal MY, Kohli P et al (2018) Supplemental Laser for Eyes Treated with Bevacizumab Monotherapy in Severe Retinopathy of Prematurity. Ophthalmol Retina 2(6):623\u2013628","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"3515_CR15","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1097\/IAE.0000000000001996","volume":"39","author":"CA Harper","year":"2019","unstructured":"Harper CA, Wright LM, Young RC et al (2019) Fluorescein angiographic evaluation of peripheral retinal vasculature after primary intravitreal ranibizumab for retinopathy of prematurity. Retina. 39(4):700\u20135","journal-title":"Retina."},{"issue":"2","key":"3515_CR16","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.ophtha.2017.08.005","volume":"125","author":"D Lepore","year":"2018","unstructured":"Lepore D, Quinn GE, Molle F et al (2018) Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings. Ophthalmology 125(2):218\u2013226","journal-title":"Ophthalmology"},{"issue":"7","key":"3515_CR17","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1097\/IAE.0b013e31820d3f70","volume":"31","author":"LY Ho","year":"2011","unstructured":"Ho LY, Ho V, Aggarwal H et al (2011) Management of avascular peripheral retina in older prematurely born infants. Retina. 31(7):1248\u201354","journal-title":"Retina."},{"issue":"3","key":"3515_CR18","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/eye.2015.289","volume":"30","author":"M Isaac","year":"2016","unstructured":"Isaac M, Tehrani N, Mireskandari K (2016) Involution patterns of retinopathy of prematurity after treatment with intravitreal bevacizumab: implications for follow-up. Eye 30(3):333\u2013341","journal-title":"Eye"},{"issue":"6","key":"3515_CR19","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1097\/IAE.0000000000001685","volume":"38","author":"Y Yonekawa","year":"2018","unstructured":"Yonekawa Y, Wu W-C, Nitulescu CE et al (2018) Progressive retinal detachment in infants with retinopathy of prematurity treated with intravitreal bevacizumab or ranibizumab. Retina. 38(6):1079\u201383","journal-title":"Retina."},{"issue":"1","key":"3515_CR20","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jaapos.2009.10.011","volume":"14","author":"JC Law","year":"2010","unstructured":"Law JC, Recchia FM, Morrison DG et al (2010) Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity. J Am Assoc Pediatr Ophthalmol Strabismus 14(1):6\u201310","journal-title":"J Am Assoc Pediatr Ophthalmol Strabismus"},{"issue":"1","key":"3515_CR21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1097\/IAE.0b013e318296e26d","volume":"34","author":"J Kim","year":"2014","unstructured":"Kim J, Kim SJ, Chang YS, Park WS (2014) Combined intravitreal bevacizumab injection and zone I sparing laser photocoagulation in patients with zone I retinopathy of prematurity. Retina. 34(1):77\u201382","journal-title":"Retina."},{"issue":"12","key":"3515_CR22","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1007\/s00417-010-1430-x","volume":"248","author":"H Nazari","year":"2010","unstructured":"Nazari H, Modarres M, Parvaresh MM, Ghasemi FK (2010) Intravitreal bevacizumab in combination with laser therapy for the treatment of severe retinopathy of prematurity (ROP) associated with vitreous or retinal hemorrhage. Graefes Arch Clin Exp Ophthalmol 248(12):1713\u20131718","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"3515_CR23","doi-asserted-by":"publisher","first-page":"3539","DOI":"10.1007\/s10792-020-01543-w","volume":"40","author":"V Laveti","year":"2020","unstructured":"Laveti V, Balakrishnan D, Rani PK et al (2020) Prospective clinical study of two different treatment regimens of combined laser photocoagulation and intravitreal bevacizumab for retinopathy of prematurity: the Indian Twin Cities ROP Study (ITCROPS) database report number 9. Int Ophthalmol 40(12):3539\u20133545","journal-title":"Int Ophthalmol"},{"key":"3515_CR24","first-page":"1","volume":"2014","author":"R Kim","year":"2014","unstructured":"Kim R, Kim YC (2014) Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity. J Ophthalmol 2014:1\u20135","journal-title":"J Ophthalmol"},{"key":"3515_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2018\/2376240","volume":"2018","author":"EJ Seo","year":"2018","unstructured":"Seo EJ, Lee JY (2018) Functional and Structural Outcomes of Temporal Zone II-Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab in Retinopathy of Prematurity. J Ophthalmol 2018:1\u20138","journal-title":"J Ophthalmol"}],"container-title":["Lasers in Medical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-022-03515-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10103-022-03515-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10103-022-03515-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T06:09:40Z","timestamp":1656050980000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10103-022-03515-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,2]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["3515"],"URL":"https:\/\/doi.org\/10.1007\/s10103-022-03515-1","relation":{},"ISSN":["1435-604X"],"issn-type":[{"value":"1435-604X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,2]]},"assertion":[{"value":"9 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Institutional Review Board of the Institutional Ethics Committee, Aravind Eye Hospital, Pondicherry (IEC-AEH-P) (AEH\/PDY\/EC\/OA\/54\/2018). The study adhered to the tenets of the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"This study does not involve any animal experiments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal research (Ethics)"}},{"value":"Informed consent was obtained from all participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed consent was obtained from all participants.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}